Serotonin and the Brain

PRESS RELEASE FROM NEUROPSYCHOPHARMACOLOGY

A PDF of the paper mentioned on this release can be found in the relevant journal's section of http://www.nature.com/npp/ . Press contacts for the journals are listed at the end of this release.  IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO http://www.nature.com/npp/

Neuroscience: Serotonin and the brain

Serotonin is used faster in the winter by people suffering from seasonal depression when compared with a control group, according to research to be published in Neurpsychopharmacology this month. The research also shows that serotonin usage returns to normal both where depression is treated effectively and during the summer months.

In depression, studies have found that the brain has too little of a neurotransmitter known as serotonin. However, why the brains of people with depression have low levels of serotonin is not known. Matthaus Williet and colleagues studied the primary way that the brain removes serotonin, known as the serotonin transporter, using an easily accessible model system: the blood platelets. The researchers tested this for a specific type of depression, known as seasonal depression; a depression that worsens in the winter and improves in the summer. This finding, if replicated, could help identify people at risk for depression and could lead to development of a new line of treatment.

Contact:
Matthaus Willeit (Medical University Vienna, Austria)
Tel: + 43 1 40 400 3543; E-mail: matthaeus.willeit@medunivien.ac.at

Editorial contact:
Diane Drexler (Neuropsychopharmacology, Nashville, TN, USA)
Tel: +1 615 324 2371; E-mail: journal@acnp.org

 

Annual Meeting

Program CoverThe ACNP Annual Meeting is one of the world's leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs.

ACNP Publications

The College offers a variety of Publications with the latest and most comprehensive research in psychopharmacology and related fields.

Research Discussions

This forum enables discussion of articles that have appeared in Neuropsychopharmacology. It is intended to stimulate scholarly interactions among researchers, and to help educate members of the public who are interested in psychiatric illness.